Healthtech Startups

MyHealthChecked provides personalized health testing infrastructure and wellness management services designed to help individuals understand their personal health priorities and make sustainable lifestyle improvements.

1 investor

1 investor

NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.

1 investor

Neobiomics develops multi-strain food supplements rooted in academic research, with collaborations across Europe. The company is affiliated with Karolinska Institutet and focuses on bringing innovative, science-based nutritional products to market.

1 investor

NeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.

1 investor

Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.

1 investor

1 investor

NeoQi manufactures spa and wellness equipment including saunas, hydrotherapy systems, and massage devices for use in spas, hotels, medical institutions, and homes. The company serves beauty salons, rehabilitation centers, and wellness facilities globally.

1 investor

NeoVac develops proprietary lipid technology for lipid nanoparticles (LNPs) designed to support mRNA-based therapeutics in vaccines, cancer immunotherapy, and autoimmune disease treatment. The company's lipid platform emphasizes tunable degradability to enhance safety and efficacy profiles.

1 investor

1 investor

Nephrodi is a biotechnology company developing treatments for kidney conditions, including the rare disease Nephrogenic Diabetes Insipidus (NDI). Its work centers on renal physiology research and translating it toward clinical products.

1 investor

Nephrolyx develops the IVDx system, combining an IVD kit with GFRx software that integrates into laboratory LIMS to measure glomerular filtration rate (mGFR) via iohexol plasma clearance for kidney function diagnostics in clinical routine. It serves physicians, clinical laboratories, and pharma/biotech companies conducting kidney research, and also offers the DNPx digital platform for research use.

1 investor

Neqabty is an Egyptian company that builds a mobile application for members of professional syndicates. Through the app, members can pay membership and service fees, handle medical costs such as prescriptions, renewals, and treatment charges, and book syndicate events and trips.

1 investor

Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.

1 investor

Nerveli develops digital support for people managing chronic pain, providing science-backed daily guidance between medical appointments through understanding pain mechanisms and nervous system responses. The platform is designed for chronic pain patients and works alongside healthcare providers.

1 investor

NervMyo Therapeutics develops a long-acting injectable delivery system combining a FDA-approved biologic (IGF-1) to improve nerve regrowth and prevent muscle wasting following peripheral nerve injury. The company targets nerve injury patients requiring regenerative therapeutics.

1 investor

Nest provides software tools to veterinary hospitals for managing pet wellness plans and preventative care programs. The platform helps clinics streamline compliance, increase wellness plan revenue, and improve pet health outcomes.

1 investor

Nested Bean designs gently weighted baby sleepwear intended to mimic a parent's touch and help infants sleep. Its product line includes swaddles, sleep sacks, footies and onesies sold direct to parents.

1 investor

Neuemoon is a health platform built to support young girls and women in understanding menstrual health and accessing information about conditions like endometriosis and fibroids. The company aims to help women recognize abnormal symptoms and connect with appropriate medical care earlier than traditional pathways.

1 investor

Neukio is a biopharmaceutical company developing iPSC-derived cell technology platforms and next-generation off-the-shelf, mass-producible immune cell products (such as NK cells) to treat solid tumors and autoimmune diseases. It focuses on innovation in both product and process development to lower cell therapy production costs and expand indication coverage.

1 investor

Neulife Rehab provides rehabilitation services for people recovering from catastrophic illness or injury. It focuses on supporting patients through the next steps of their recovery.

1 investor

Neumentum is a specialty pharmaceutical company developing non-opioid analgesic and neurology products for pain management. It has four novel non-opioid products in development aimed at treating pain while avoiding the abuse, misuse, and respiratory side effects associated with opioids.

1 investor

Neupulse develops a wearable device that delivers drug-free, non-invasive neurostimulation to support everyday wellbeing and relaxation, based on neuroscience research. It sells a consumer wellness device with an accompanying app, and is also developing a clinical version currently going through regulatory approval, with an initial launch planned in Great Britain.

1 investor

NeurAbilities Healthcare provides diagnostic and therapeutic services for patients with neurological and developmental conditions, combining precision medicine, behavioral sciences, and therapeutic treatments. It serves patients seeking neurological and behavioral healthcare.

1 investor